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Introduction: A 60-year-old man presented with a 6-month history of low back pain 
and progressive rigidity of the trunk and lower limbs, followed by pruritus, dysphonia, 
hyperhydrosis, and urinary retention. Brain and spinal imaging were normal. EMG 
showed involuntary motor unit hyperactivity. Onconeural, antiglutamic acid decar-
boxylase (anti-GAD), voltage-gated potassium channel, and dipeptidyl peptidase-like 
protein 6 (DPPX) autoantibodies were negative. CSF was negative. Symptoms were 
partially responsive to baclofen, gabapentin, and clonazepam, but he eventually devel-
oped severe dysphagia. Antiglycine receptor (anti-GlyR) antibodies turned out positive 
on both serum and CSF. A plasmapheresis cycle was completed with good clinical 
response. A PET scan highlighted an isolated metabolically active axillary lymphnode 
that turned out to be a classic type Hodgkin lymphoma (HL), in the absence of bone 
marrow infiltration nor B symptoms. Polychemotherapy with ABVD protocol was com-
pleted with good clinical response and at 1-year follow-up the neurological examination 
is normal.
Background: Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a 
rare and severe neurological syndrome characterized by muscular rigidity and spasms 
as well as brain stem and autonomic dysfunction. It can be associated with anti-GAD, 
GlyR, and DPPX antibodies. All of these autoantibodies may be variably associated with 
malignant tumors and their response to immunotherapy, as well as to tumor removal, is 
not easily predictable.
Conclusion: Progressive encephalomyelitis with rigidity and myoclonus has already 
been described in association with HL, but this is the first case report of a HL man-
ifesting as anti-GlyR antibodies related PERM. Our report highlights the importance 
of malignancy screening in autoimmune syndromes of suspected paraneoplastic 
origin.
Keywords: progressive encephalomyelitis with rigidity and myoclonus, glycine receptor antibodies, paraneoplastic 
syndromes, stiff person syndrome, Hodgkin’s lymphoma
FIGURe 1 | (a) T2 abdominal MRI revealing left psoas and bilateral paravertebral muscles edema and fatty substitution. (B–D) Total body CT-PET showing a 
hypermetabolic left axillary lymph node. We did not use copyrighted material from other sources (including the web).
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INtRoDUCtIoN
A 60-year-old previously healthy man was referred to our hospital 
for subacute onset of severe and progressive gait disturbance 
associated with painful muscular spasms of the trunk and lower 
limbs. Symptoms appeared 5  months before with lumbar and 
left leg pain, followed by progressive gait difficulty especially in 
climbing stairs. At that time a first neurological examination was 
unremarkable except for positive Lasègue sign on the right side; 
75  mg of oral prednisone was prescribed, with a partial relief 
of symptoms. Three months after symptoms, onset spontane-
ous and stimulus sensitive muscular spasms appeared, and an 
EMG confirmed involuntary continuous motor unit activity of 
all examined muscles. At that time a neurological examination 
disclosed bilateral achilleus clonus associated with clubfoot and 
mallet fingers. Blood creatine kinases were slightly increased (up 
to 518 U/L), while autoantibodies [ANA, ENA, anti Hu-Yo-Ri-
Amphiphysin-CV2-Ma2/Ta, and antiglutamic acid decarboxy-
lase (anti-GAD)] were negative. Cerebrospinal fluid examination 
was normal. In order to rule out paraneoplastic syndromes, a total 
body CT scan was performed, showing two small axillary lymph 
nodes (defined as reactive) and a diffuse swelling and edema of 
left psoas, iliacus, pectineus, obturator externus, and quadratus 
lumborum, which was attributed to focal myositis. He was 
then treated with intravenous methylprednisolone followed by 
1 mg/kg of oral prednisone. Despite treatment, he became wheel-
chair bound and was sent to rehabilitation, where he developed 
progressive dysphonia and diffuse pruritus on steroid tapering. 
For this reason he was admitted to our hospital.
Neurological examination showed marked dysphonia with 
rhynolalia and slight bilateral facial weakness. Ocular movements 
were unaffected. Marked truncal and proximal lower limb rigidity, 
with incapacity to sit and stand unassisted, was noticed. Diffuse 
hyperreflexia with knee and ankle clonus was elicited. Cutaneous 
plantar reflex was flexor. He also had diffuse hyperhydrosis, 
constipation, and urinary retention. A therapy with oxibutinine 
and tamsulosine was prescribed, but he still required frequent 
autocatheterization. No muscular weakness, cerebellar signs, 
nor sensory defects were detected. However, he complained of 
severe dysesthesias and diffuse pruritus. After admission, he also 
developed severe dysphagia, requiring a feeding tube.
EMG was unremarkable, also in the paravertebral muscles. 
There was an increased cortical latency at both motor and sensory 
evoked potentials at the four limbs but brain and spinal MRI 
showed no abnormality except from the muscular swelling that 
had been mentioned at the first CT (Figure 1A). EEG was normal 
and there were no cognitive or psychiatric symptoms. A PET scan 
highlighted one of the two previously reported axillary lymph 
nodes as being enlarged and metabolically active (Figures 1B–D).
Symptoms markedly improved with clonazepam (up to 
2.5 mg/day) and gabapentin (up to 1.200 mg/day). Steroid dosage 
increase up to 50 mg lead to a partial relief of sensory symptoms.
Blood tests were normal, including previously tested autoanti-
bodies, voltage-gated potassium channel complex, and dipeptidyl 
peptidase-like protein 6 (DPPX) antibodies. GAD antibodies 
were still negative, as well as CSF examination, including protein 
level, IgG, and OGB. Finally, anti–GlyR (antiglycine receptor) 
antibodies were found to be positive on both serum and CSF sam-
ples, respectively. Meanwhile the patient started a plasmapheresis 
treatment, five cycles, 3,000 mL/cycle.
The metabolically active anxillary lymph node was removed 
and its histological examination was consistent with a classic 
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type Hodgkin’s lymphoma. Of note, there was no bone marrow 
infiltration, no elevation in β2-microglobulin, nor lactate dehy-
drogenase in blood. Partial clinical improvement was observed 
10 days after plasmapheresis. The patient was then able to stand 
unassisted and walk with minimal help. Dysphagia completely 
resolved few weeks after. He eventually was transferred at the 
Oncoematology Division to undergo polychemotherapy with 
ABVD protocol (doxorubicin, bleomycin, vinblastine, and dac-
arbazine). Over a 12-month follow-up period, a constant clinical 
improvement was observed despite tapering of immunosuppres-
sive and symptomatic treatment. The patient was able to walk 
unassisted, to carry out usual activities including a full time job. 
He was still symptomatic for inconstant self-resolving stiffness in 
the morning (12 months mRS score was 1). A control PET scan 
was negative. The abdominal and pelvic muscles had a normal 
MRI appearance.
Written informed consent was obtained from the participant 
for the publication of this case report.
BaCKGRoUND
Progressive encephalomyelitis with rigidity and myoclonus 
(PERM) was first described 40 years ago by Whiteley et al. (1). 
It was also called stiff person plus syndrome, sharing some of its 
core clinical features and being sometimes associated with GAD 
autoimmunity. In 2008, anti-GlyR antibodies were detected in a 
typical PERM patient with hyperekplexia, rigidity, and brain stem 
signs (2), and in the following years, more cases were reported 
(3–8). An association with tumor has been reported in about 20% 
of cases (9) Recently, a novel antibody, namely anti-DPPX was 
reported to be associated with PERM with frequent gastrointes-
tinal involvement (10–12). Another case report associates PERM 
to amphiphysin antibodies (13).
All of these autoantibodies have been related in variable 
frequency to malignant tumors and their response to immuno-
therapy, as well as tumor removal, is also not easily predictable 
(9–14).
DIsCUssIoN
To our knowledge, this is the first case report of a Hodgkin’s 
lymphoma manifesting as glycine-receptor antibodies related 
PERM. In their prospective analysis of 45 GlyR antibodies posi-
tive patients, Carvajal-Gonzàlez et al. reported a case of PERM/
myastenia gravis plus syndrome in a 51-year-old male with a past 
history of successfully treated Hodgkin’s lymphoma (14). Schmidt 
et al. describe a patient presenting with generalized pruritus, sleep 
disturbance and paroxismal fear, followed by rapidly progressive 
gait ataxia, generalized myoclonic jerks, severe dysautonomia, 
and respiratory failure who eventually developed a Hodgkin’s 
lymphoma (15). There was no screening for antibodies against 
GlyR; however, the presence of status epilepticus and psychiatric 
features might also suggest an NMDAR encephalitis. In this 
regard, an overlap of the syndromes associated with both GlyR 
and NMDAR antibodies was described (5). The absence of sei-
zures, psychiatric symptoms, and signs of hippocampal involve-
ment in our patient did non-prompt us to investigate NMDAR 
autoimmunity. McKeon et  al. also report a case of stiff person 
syndrome with GlyR antibodies in a young man who 12  years 
later was diagnosed with Hodgkin’s lymphoma. However, he 
never developed signs of brain stem involvement and the timing 
of the malignancy diagnosis makes this association questionable 
(16). Our patient did not complain systemic symptoms of malig-
nancy. However, hyperhydrosis and itching, that are common in 
non-paraneoplastic PERM (14), could be interpreted as B symp-
toms as well. At CT scan, the lymphoma was overlooked, being 
described as a probably reactive lymph node. This highlights the 
importance of performing a more sensitive PET scan in patients 
with a strong suspect of a paraneoplastic syndrome.
Imaging showed atypical features in the abdominal and pel-
vic muscles. Such findings have not been described before and 
were partly misleading for diagnosis and treatment, since they 
suggested a focal myositis. The muscular edema resolving soon 
after symptomatic therapy rather than with immunotherapy sug-
gests a possible association to hypercontraction rather than an 
inflammatory process. Interestingly, we noticed a similar CT and 
MRI muscle images in a young woman with anti-GAD-related 
stiff person syndrome with myopathic discharges at EMG, which 
eventually evolved into fibrous substitution.
In summary, we presented a case of PERM with GlyR anti-
bodies as first manifestation of Hodgkin’s lymphoma. A correct 
interpretation of symptoms and imaging investigations is of 
primary importance to rule out an underlying occult malignancy 
and speed up the appropriate treatment.
etHICs stateMeNt
The study was exempt from this requirement. Non-applicable. 
The current study does not involve vulnerable populations.
aUtHoR CoNtRIBUtIoNs
LB and SL: clinical assessment, acquisition of data, manuscript 
drafting. SB, IT, GF, and LT: clinical assessment, acquisition of 
data. NB: clinical assessment, critical revision of manuscript. AD: 
critical revision of manuscript.
ReFeReNCes
1. Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. 
Brain (1976) 99:27–42. doi:10.1093/brain/99.1.27 
2. Hutchinson M, Waters P, McHugh J, Gorman G, O’Riordan S, Connolly S, 
et  al. Progressive encephalomyelitis, rigidity and myoclonus: a novel gly-
cine receptor antibody. Neurology (2008) 71:1291–2. doi:10.1212/01.wnl. 
0000327606.50322.f0 
3. Clerinx K, Breban T, Schrooten M, Leite MI, Vincent A, Verschakelen J, 
et  al. Progressive encephalomyelitis with rigidity and myoclonus: resolu-
tion after thymectomy. Neurology (2011) 76:303–4. doi:10.1212/WNL. 
0b013e318207b008 
4. Piotrowicz A, Thümen A, Leite MI, Vincent A, Moser A. A case of glycine- 
receptor antibody-associated encephalomyelitis with rigidity and myoclo-
nus (PERM): clinical course, treatment and CSF findings. J Neurol (2011) 
258:2268–70. doi:10.1007/s00415-011-6078-x 
4Borellini et al. Hodgkin’s Lymphoma Manifesting with PERM
Frontiers in Neurology | www.frontiersin.org August 2017 | Volume 8 | Article 401
5. Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive 
encephalomyelitis with rigidity and myoclonus. Neurology (2011) 77:439–43. 
doi:10.1212/WNL.0b013e318227b176 
6. Mas N, Saiz A, Leite M, Waters P, Baron M, Castaño D, et al. Antiglycine-
receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatr (2011) 
82:1399–401. doi:10.1136/jnnp.2010.229104 
7. Iizuka T, Leite M, Lang B, Waters P, Urano Y, Miyakawa S, et  al. Glycine 
receptor antibodies are detected in progressive encephalomyelitis with rigid-
ity and myoclonus (PERM) but not in saccadic oscillations. J Neurol (2012) 
259:1566–73. doi:10.1007/s00415-011-6377-2 
8. Stern WM, Howard R, Chalmers RM, Woodhall MR, Waters P, Vincent A, 
et al. Glycine receptor antibody mediated progressive encephalomyelitis with 
rigidity and myoclonus (PERM): a rare but treatable neurological syndrome. 
Pract Neurol (2014) 14:123–7. doi:10.1136/practneurol-2013-000511 
9. Baizabal-Carvallo JF, Jankovic J. Stiff-person syndrome: insights into a com-
plex autoimmune disorder. J Neurol Neurosurg Psychiatry (2015) 86:840–8. 
doi:10.1136/jnnp-2014-309201 
10. Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, et al. 
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit 
of Kv4.2 potassium channels. Ann Neurol (2013) 73:120–8. doi:10.1002/
ana.23756 
11. Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blöcker IM, et al. Progressive 
encephalomyelitis with rigidity and myoclonus. A new variant with DPPX 
antibodies. Neurology (2014) 84:1521–8. doi:10.1212/WNL.0000000000000372 
12. Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, 
et al. DPPX potassium channel antibody. Frequency, clinical accompaniments, 
and outcomes in 20 patients. Neurology (2014) 83:1797–803. doi:10.1212/
WNL.0000000000000991 
13. Ishii A, Hayashi A, Ohkoshi N, Matsuno S, Shoji S. Progressive encephalo-
myelitis with rigidity associated with anti-amphiphysin antibodies. J Neurol 
Neurosurg Psychiatry (2004) 75:661–2. doi:10.1136/jnnp.2003.010504
14. Carvajal-Gonzàlez A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, 
et al. Glycine receptor antibodies in PERM and related syndromes: character-
istics, clinical features and outcomes. Brain (2014) 137:2178–92. doi:10.1093/
brain/awu142 
15. Schmidt C, Freilinger T, Lieb M, Rémi J, Klein M, Straube A, et al. Progressive 
encephalomyelitis with rigidity and myoclonus preceding otherwise asymp-
tomatic Hodgkin’s lymphoma. J Neurol Sci (2010) 291:118–20. doi:10.1016/j.
jns.2009.12.025 
16. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, 
McEvoy KM, et  al. Glycine receptor autoimmune spectrum with stiff-man 
syndrome phenotype. JAMA Neurol (2013) 70(1):44–50. doi:10.1001/
jamaneurol.2013.574 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2017 Borellini, Lanfranconi, Bonato, Trezzi, Franco, Torretta, Bresolin 
and Di Fonzo. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License (CC BY). The use, distribution or reproduction in 
other forums is permitted, provided the original author(s) or licensor are credited 
and that the original publication in this journal is cited, in accordance with accepted 
academic practice. No use, distribution or reproduction is permitted which does not 
comply with these terms.
